top of page

HOW?

Adhesive

Bonding Agent 

Substrate

Mesh Matrix

Micro Needle

Penatration

Release Liner

Dermal Absorbtion

Application Device

Hygenic Delivery  

Learn More

MICRONEEDLE PATCH

MICRONEEDLE PATCH: BACKGROUND

Creation of the Microneedle Patch

The microneedle patch is composed of several needles attached to a flat patch. Small caches in the patch hold treatments that are expelled out through the needles. After use, the patch can be disposed of in normal waste containers. Nanoparticles are primarily stored in the cache deposits, becoming efficient drug carriers for the molecules that will enter the body.

    

The needles of the patch are also composed of water soluble polymers that dissolve into the skin's dermal layers. This specific region of treatment allows for the needles to directly target the Lagerhan cells to directly vaccinate the immune system without directly entering the bloodstream, requiring lower dosages than the standard needle injections.

​

H.C-5

WHEN AND WHERE?

WHY?

The microneedle patch is now been used for several purposes, but the innovation's initial purpose was to deliver medication through the patch. Seeing a need for a cost-effective and painless method of drug delivery, researchers at Drug Delivery Systems Inc. sought to develop the patch for communities that lack the infrastructure and resources to have standard needle injections. 

​

H.C-1

Imunology
​

The patch has the ability to vaccinate any individual in a pain free manner, easing the stigma of vaccinations in certain communities.

Find Out More

THE FUTURE

The patch faces challenges of distribution. Specifically, while cutting on transportation costs, microneedle patches are more expensive than standard needles to manufacture, and therefore, researchers face challenges in developing a microneedle patch that is both inexpensive to produce and effective for the public.

The patch has made significant improvements pushing it toward clinical stages of testing. From innovators developing small pores to maximize treatment delivery, or clinical research initiatives where researchers first vaccinate Papua New Guineans, the microneedle patch is constantly changed and improved to make the patch more easy to transport and quicker to deliver drugs.

The patch was first developed in the United States in the '90s, but since then, the microneedle patch has continuously changed and developed across the globe.*

 

In Australia, the United Kingdom, and the United States of America, the patch has been developed as a vaccination and treatment tool. **

 

In Papua New Guinea, the patch has been tested to help vaccinate communities cost effectively. In South Korea, the patch has been developed primarily to serve as a cosmetic treatment.***

​

The UK

Since the early 2000's , England-based companies, such P&G, have funded research at universities in developing the patch, such as Oxford University, Nottingham University, and Queen's College. Ryan Donnelly has also made siginifcant leaps in creating a hydrogel patch in his own research team.

H.C-12

The United Kingdom
 England
 Ireland
Papua New Guinea

In this developing nation, nano patches (microneedle patches) have been used to vaccinate many individuals in 2013  

H.C-10

Papua New Guinea
The United States of America

American companies, such as Drug Delivery Systems and Corium, have funded research since the early 1990's. University researchers such as Georgia Technical Institute's Mark Prausnitz has made huge leaps in innovation since the early  2000's. Philanthropy groups like the Bill and Melinda Gates Foundation have also been funding research as well.

H.C-13

The United States of America
South Korea
South Korea

The Foundation of Korean Cosmetic Industry Institute has made headway developing the patch for cosmetic use since the  2010's.

H.C-9

Australia
Australia

Mark Kendall of University of Queensland developed the microneedle patch in the early 2000's. He has sold his patch to VAXXAS a drug delivery company, in 2013,  to distribute and further improve the patch.

H.C-11

Hover Over Each Nation
* = H.C - 6
** = H.C - 7
*** = H.C-8

The patch has proven much of its abilities and potential in many clinical studies. In the future, the patch's abilities will be first applied to creating vaccines for HPV and polio and released for public use. In doing so, this cheap, durable, and easy application drug delivery technique could vaccinate the globe leading toward the irradiation of more diseases

Oncology

The patch has the ability to stimulate the CD4 and CD8+ cells which can potentially prevent cancer.

Find Out More
Humanitarian
Efforts
Find Out More

In developing nations that lack the equipment, facilities, and resources for effective vaccination, these patches could be extremely beneficial.

bottom of page